Interleukin-33 antibody failed to demonstrate benefit in a phase II, double-blind, randomized, placebo-controlled study in adult patients with moderate-to-severe atopic dermatitis
العنوان: | Interleukin-33 antibody failed to demonstrate benefit in a phase II, double-blind, randomized, placebo-controlled study in adult patients with moderate-to-severe atopic dermatitis |
---|---|
المؤلفون: | Vivian Laquer, Viviana Parra, Jean-Philippe Lacour, Hidetoshi Takahashi, Jack Knorr, Angela J. Okragly, Douglas E. James, Jonathan T. Sims, Ching-Yun Chang, Jeannie Chao, Paul Klekotka |
المصدر: | British Journal of Dermatology. 187:599-602 |
بيانات النشر: | Oxford University Press (OUP), 2022. |
سنة النشر: | 2022 |
مصطلحات موضوعية: | Dermatology |
تدمد: | 1365-2133 0007-0963 |
URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_________::a4dbcc28700962595ae0de478cd7e900 https://doi.org/10.1111/bjd.21631 |
حقوق: | CLOSED |
رقم الأكسشن: | edsair.doi...........a4dbcc28700962595ae0de478cd7e900 |
قاعدة البيانات: | OpenAIRE |
تدمد: | 13652133 00070963 |
---|